公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1995 | Photodynamic effect on breast and colon cancer cells of use of merocyanine 540 as a photosensitizer | CHIUN-SHENG HUANG ; Huang S.-H.; Lin T.-I.; KING-JEN CHANG | Journal of Surgical Association Republic of China | 0 | | |
2008 | Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan | Cheng C.-W.; Yu J.-C.; CHIUN-SHENG HUANG ; Shieh J.-C.; Fu Y.-P.; Wang H.-W.; Wu P.-E.; Shen C.-Y. | Breast Cancer Research and Treatment | 43 | 41 | |
2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
2020 | Potent cell-cycle inhibition and upregulation of immune response with abemaciclib and anastrozole in Neomonarch, phase II neoadjuvant study in HR+/HER2- Breast cancer | Hurvitz S.A.; Martin M.; Press M.F.; Chan D.; Fernandez-Abad M.; Petru E.; Rostorfer R.; Guarneri V.; CHIUN-SHENG HUANG ; Barriga S.; Wijayawardana S.; Brahmachary M.; Ebert P.J.; Hossain A.; Liu J.; Abel A.; Aggarwal A.; Jansen V.M.; Slamon D.J. | Clinical Cancer Research | 126 | 111 | |
2010 | Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin | YU-YUN SHAO ; KUAN-TING KUO ; Hu F.-C.; YEN-SHEN LU ; CHIUN-SHENG HUANG ; JAU-YU LIAU ; Lee W.-C.; CHIUN HSU ; WEN-HUNG KUO ; KING-JEN CHANG ; CHING-HUNG LIN ; ANN-LII CHENG | Japanese Journal of Clinical Oncology | 28 | 24 | |
2019 | A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer | Yang, Po-Sheng; Lee, Yi-Hsuan; Chung, Chi-Feng; Chang, Yuan-Ching; Wang, Ming-Yang; Chiao Lo ; TSAI, LI WEI ; Shih, Kuan-Hui; Lei, Jason; Yu, Ben-Long; Cheng, Skye H; CHIUN-SHENG HUANG | Japanese journal of clinical oncology | 8 | 8 | |
2012 | Preoperative systemic therapy in locoregional management of early breast cancer: Highlights from the Kyoto Breast Cancer Consensus Conference | Toi M.; Benson J.R.; Winer E.P.; Forbes J.F.; Von Minckwitz G.; Golshan M.; Robertson J.F.R.; Sasano H.; Cole B.F.; Chow L.W.C.; Pegram M.D.; Han W.; CHIUN-SHENG HUANG ; Ikeda T.; Kanao S.; Lee E.-S.; Noguchi S.; Ohno S.; Partridge A.H.; Rouzier R.; Tozaki M.; Sugie T.; Yamauchi A.; Inamoto T. | Breast Cancer Research and Treatment | 5 | 5 | |
2008 | Primary leiomyosarcoma of the nipple-areola complex: Report of a case and review of literature | Luh S.-P.; Wong L.-C.; Huang P.-C.; CHIUN-SHENG HUANG | Journal of Zhejiang University: Science B | 13 | 11 | |
2022 | Prognostic Comparison between Oncotype DX® and a 23-Gene Classifier, RecurIndex®, on the Taiwan Breast Cancer Population | Chang, Chuan-Hsun; Yang, Po-Sheng; Hsieh, Chia-Ming; Chen, Ting-Hao; Cheng, Skye Hung-Chun; Yang, Cheng-En; CHIUN-SHENG HUANG | Diagnostics (Basel, Switzerland) | 0 | 0 | |
2002 | Prognostic factors for the survival of Taiwanese breast cancer patients | WEI-CHU CHIE ; SHU-HUI CHANG ; CHIUN-SHENG HUANG ; Tzeng S.-J.; JEN-HAU CHEN ; Fan B.-Y.; KING-JEN CHANG | Journal of the Formosan Medical Association | 15 | 14 | |
2011 | Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients? | CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG | Journal of Clinical Pathology | 8 | 8 | |
2018 | Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery | SUNG-HSIN KUO ; Chiao Lo ; YU-HSUAN CHEN ; HUANG-CHUN LIEN ; WEN-HUNG KUO ; Wang, Ming-Yang; Lee, Yi-Hsuan; CHIUN-SHENG HUANG | Clinical Breast Cancer | 8 | 5 | |
1998 | The prognostic significance of pathologic characteristics of breast cancer patients in Taiwan | Chu J.-S.; CHIUN-SHENG HUANG ; KING-JEN CHANG | Tzu Chi Medical Journal | 0 | | |
1998 | The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas | Chu J.-S.; CHIUN-SHENG HUANG ; KING-JEN CHANG | Cancer Letters | 12 | 8 | |
1998 | Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan | Chu J.-S.; CHIUN-SHENG HUANG ; KING-JEN CHANG | Cancer Letters | 20 | 20 | |
2003 | Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23 | WEI-CHU CHIE ; KING-JEN CHANG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO | Psycho-Oncology | 83 | 70 | |
2016 | Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI | RUEY-FENG CHANG ; Chen H.-H.; YEUN-CHUNG CHANG ; CHIUN-SHENG HUANG ; Chen J.-H.; Lo C.-M. | Magnetic Resonance Imaging | 67 | 60 | |
2014 | Quantitative analysis for breast density estimation in low dose chest CT scans | Woo Kyung Moon; Chung-Ming Lo; Jin Mo Goo; Min Sun Bae; Jung Min Chang; CHIUN-SHENG HUANG ; Jeon-Hor Chen; Violeta Ivanova; RUEY-FENG CHANG | Journal of Medical Systems | 14 | 16 | |
2015 | Quantitative analysis of breast echotexture patterns in automated breast ultrasound images | Chang R.-F.; Hou Y.-L.; Lo C.-M.; CHIUN-SHENG HUANG ; Chen J.-H.; Kim W.H.; Chang J.M.; Bae M.S.; Moon W.K. | Medical Physics | 10 | 10 | |
2018 | Quantitative breast density analysis using tomosynthesis and comparison with MRI and digital mammography | Moon, W.K.; Chang, J.-F.; Lo, C.-M.; Chang, J.M.; Lee, S.H.; Shin, S.U.; CHIUN-SHENG HUANG ; RUEY-FENG CHANG | Computer Methods and Programs in Biomedicine | 11 | 11 | |